That RAF/MEK/ERK and PI3K/AKT/mTOR are tightly intertwined and compensate for each other has been further confirmed by the combinatorial effects of MEK and AKT inhibitors in RAS-mutated multiple myeloma, which significantly increased apoptotic cell death compared with single agents (29). The gene discussed is MAP2K7; the disease is plasma cell myeloma.